Promotion of Cialis Together (tadalafil) by Bestway Panacea Holdings Ltd - March 2024
Published 28 June 2024
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-march-2024/promotion-of-cialis-together-tadalafil-by-bestway-panacea-holdings-ltd-march-2024
March 2024 Promotion of Cialis Together (tadalafil) by Bestway Panacea Holdings Ltd t/a Wells Pharmacy
In February 2024, a member of the public and Perrigo Company Plc complained about an advertisement to the general public for Cialis Together (tadalafil, a medicine with P [Pharmacy] legal status indicated for erectile dysfunction) produced as a shelf tray seen at 2 Well Pharmacy premises in the Stoke-on-Trent area between July 2023 and February 2024. The complainants alleged that the shelf tray inappropriately promoted the above medicine as being better than another named, identifiable over-the-counter (OTC) medicine.
MHRA upheld the complaint based on the view that the advertisement was in breach of regulation 287 (1b) of the Human Medicines Regulations 2012, which states that a person may not publish an advertisement relating to a medicinal product that suggests that the effects of taking the medicinal product… are better than or equivalent to those of another identifiable treatment or medicinal product. This prohibition is strongly supported by specific guidance in the Consumer Code published by the Proprietary Association of Great Britain.
Bestway Panacea Holdings Ltd t/a Wells Pharmacy confirmed that they have withdrawn the advertisement from use and that the claim in question would not be used in any future promotional material.